• About Us
    • Corporate Profile
    • Global Footprint
    • Our Key Milestones
    • BOD
  • manufacturing
    • Infrastructure
    • Dosage Forms & Capacities
  • products & services
    • Products
    • Services
    • Join Hands With Naxpar
  • Investor relations
    • Financials
    • Shareholders Information
    • Compliance
    • Disclosure under Regulation 46 & 62 of SEBI (LODR) Regulations, 2015
    • Investor Contact
  • Catalogues
    • Naxpar Specialities
    • Naxpar Generics
  • Contact Us
    • Contact Us
    • Adverse Event Reporting
Financials ofSubsidiary
Year ended March 31st 2017
Financial
Download
Year ended March 31st 2018
Financial
Download
Year ended March 31st 2019
Financial
Download
Year ended March, 2020
Financial
Download
Year Ended March 31st, 2021
Financial
Download
Year Ended March 31st, 2022
Financial
Download
Year Ended March 31st, 2023
Financial
Download
Year Ended March 31st, 2024
Financial
Download
Copyrights Reserved 2008-2025. Naxpar Group